CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 89 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $16,000 | +100.0% | 1,895 | +120.1% | 0.00% | – |
| Q4 2019 | $8,000 | 0.0% | 861 | -34.4% | 0.00% | -100.0% |
| Q3 2019 | $8,000 | +100.0% | 1,312 | +338.8% | 0.00% | – |
| Q2 2019 | $4,000 | +100.0% | 299 | +118.2% | 0.00% | – |
| Q4 2018 | $2,000 | – | 137 | +389.3% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 28 | -99.6% | 0.00% | -100.0% |
| Q2 2018 | $106,113,000 | +558389.5% | 6,305 | +679.4% | 0.01% | +350.0% |
| Q1 2018 | $19,000 | +280.0% | 809 | +274.5% | 0.00% | – |
| Q4 2017 | $5,000 | +66.7% | 216 | -5.3% | 0.00% | – |
| Q3 2017 | $3,000 | -40.0% | 228 | -36.1% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 357 | +20.2% | 0.00% | – |
| Q1 2017 | $5,000 | -66.7% | 297 | -80.2% | 0.00% | -100.0% |
| Q4 2016 | $15,000 | – | 1,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |